Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Development of a Cold Agglutinin Disease-Specific Patient-Reported Outcome Symptom Measure

Florence Joly, Pronabesh Dasmahapatra, Jun Su, Dana DiBenedetti, Katherine Kosa, Quentin Hill

Blood (2021) 138 (Supplement 1): 4057.

https://doi.org/10.1182/blood-2021-147199

Published: 2021

Journal Articles

Effect of Sutimlimab Treatment on Healthcare Resource Utilization in Patients with Cold Agglutinin Disease

Alexander Röth, MD, Sophie Guillonneau, Nadege Narcisse, Paulo Carita, Jun Su, Florence Joly

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-139738

Published: 2020

Journal Articles

Inflammation and Fatigue in Patients with Cold Agglutinin Disease (CAD): Analysis from the Phase 3 Cardinal Study

Ilene C. Weitz, Yasutaka Ueda, Frank Shafer, Jun Su, Meredith Foster, Michael Storek, Parija Patel

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-140335

Published: 2020

Journal Articles

Treatment Patterns Among Patients with Immune Thrombocytopenia (ITP) in the United States: An Electronic Medical Record (EMR)-Based Analysis

Amanda Wilson, Ahmed Daak, Jun Su

Blood (2020) 136 (Supplement 1): 43.

https://doi.org/10.1182/blood-2020-140409

Published: 2020

Journal Articles

Medically Attended Anxiety or Depression Is Increased Among Newly Diagnosed Patients with Cold Agglutinin Disease (CAD)

Parija Patel, Xiaohui Jiang, Gina Nicholson, Cara Frankenfeld, Melitza Iglesias-Rodriguez, Jon P Fryzek, Jun Su

Blood (2020) 136 (Supplement 1): 28.

https://doi.org/10.1182/blood-2020-139791

Published: 2020

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up

Alexander Röth, MD, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, MD, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C. Weitz, Parija Patel, Xiaoyu Jiang, Caroline Reuter, Jun Su, Frank Shafer, Michelle Lee, William Hobbs, Sigbjørn Berentsen

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138909

Published: 2020

Journal Articles

Patient-Reported Disease Burden: In-Depth Interviews of Patients with CAD

Jun Su, Katherine Kosa, Dana DiBenedetti

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-136788

Published: 2020

Journal Articles

Patients' and Caregivers' Preferences for Different Hemophilia a Treatment Attributes

Namita Joshi, PhD MS, BPharm, Xinyi Ng, Marc Botteman, MS, MA, Nanxin Li, Rachel Shah, BS, Nisha Jain, Nicole Lyn, Jun Su

Blood (2019) 134 (Supplement_1): 2122.

https://doi.org/10.1182/blood-2019-126774

Published: 2019

Journal Articles

Cold Agglutinin Disease Transfusion Practices in the United States: An Electronic Medical Record-Based Analysis

Jun Su, Rajeshwari Punekar, Jaime Morales Arias, Nisha Jain

Blood (2019) 134 (Supplement_1): 3690.

https://doi.org/10.1182/blood-2019-122209

Published: 2019

Journal Articles

Mortality Among Patients with Cold Agglutinin Disease in the United States: An Electronic Health Record (EHR)-Based Analysis

Quentin A. Hill, Rajeshwari Punekar, Jaime Morales Arias, Catherine M Broome, MD, Jun Su

Blood (2019) 134 (Supplement_1): 4790.

https://doi.org/10.1182/blood-2019-122140

Published: 2019

Journal Articles

Changing the Paradigm in Hemophilia Care: Extended Half-Life Products (rFVIIIFc and rFIXFc)

Louis M. Aledort, MD, Nisha Jain, MBBS,MD, Nanxin Li, Sangeeta Krishnan, PharmD, Benjamin Hagberg, Jun Su, MD

Blood (2018) 132 (Supplement 1): 3514.

https://doi.org/10.1182/blood-2018-99-114905

Published: 2018

Journal Articles

Economic Impact of Immune Tolerance Induction (ITI) with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Compared to Conventional Recombinant Factor VIII (rFVIII)

Nanxin Li, Koo Wilson, Marc Botteman, MS, MA, Daniel Nicoloso, Sangeeta Krishnan, PharmD, Jun Su, MD

Blood (2018) 132 (Supplement 1): 3520.

https://doi.org/10.1182/blood-2018-99-114993

Published: 2018

Journal Articles

Costs of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) - an Analysis of German Claims Data

Moritz Lehne, PhD, Lennart Hickstein, MPH, Tayyab Salimullah, BSc, Jun Su, MD, Sigurd Prieur, PhD, Simu K Thomas, PhD

Blood (2016) 128 (22): 5932.

https://doi.org/10.1182/blood.V128.22.5932.5932

Published: 2016

Journal Articles

The Immune Tolerance Induction Factor Utilizations and Costs for the Management of Male Hemophilia-a Patients Who Developed Inhibitors

Jun Su, MD, Jia Zhou, Brieana Buckley, MS, PharmD, Tom Rising, Qiang Hou, Nisha Jain

Blood (2016) 128 (22): 4758.

https://doi.org/10.1182/blood.V128.22.4758.4758

Published: 2016

Journal Articles

Suppression of the Immune Response to Human FVIII with FVIII Transgene Modified Tolerogenic Dendritic Cells in Hemophilic Mice

Rui-Jun Su, Ph.D, Angela Epp, Xiaoping Wu, Ph.D, Neil Josephson, MD

Blood (2008) 112 (11): 591.

https://doi.org/10.1182/blood.V112.11.591.591

Published: 2008

Journal Articles

Induction of Tolerance to FVIII in Hemophilic Mice by Delivery of Apoptotic Syngeneic Fibroblasts Expressing a FVIII Transgene.

Rui-Jun Su, MD, PhD, Laura Stewart, Angela Epp, Steven W. Pipe, MD, Neil C. Josephson, MD

Blood (2006) 108 (11): 768.

https://doi.org/10.1182/blood.V108.11.768.768

Published: 2006

Journal Articles

Reduction of Anti-FVIII Inhibitor Titers in Hemophilic Mice Infused with Syngeneic Apoptotic Cells Expressing a Human FVIII Transgene.

Rui-Jun Su, MD, PhD, Laura Stewart, Steven W. Pipe, MD, Neil C. Josephson, MD

Blood (2005) 106 (11): 216.

https://doi.org/10.1182/blood.V106.11.216.216

Published: 2005

NARROW

Development of a Cold Agglutinin Disease-Specific Patient-Reported Outcome Symptom Measure

Effect of Sutimlimab Treatment on Healthcare Resource Utilization in Patients with Cold Agglutinin Disease

Inflammation and Fatigue in Patients with Cold Agglutinin Disease (CAD): Analysis from the Phase 3 Cardinal Study

Treatment Patterns Among Patients with Immune Thrombocytopenia (ITP) in the United States: An Electronic Medical Record (EMR)-Based Analysis

Medically Attended Anxiety or Depression Is Increased Among Newly Diagnosed Patients with Cold Agglutinin Disease (CAD)

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up

Patient-Reported Disease Burden: In-Depth Interviews of Patients with CAD

Patients' and Caregivers' Preferences for Different Hemophilia a Treatment Attributes

Cold Agglutinin Disease Transfusion Practices in the United States: An Electronic Medical Record-Based Analysis

Mortality Among Patients with Cold Agglutinin Disease in the United States: An Electronic Health Record (EHR)-Based Analysis

Changing the Paradigm in Hemophilia Care: Extended Half-Life Products (rFVIIIFc and rFIXFc)

Economic Impact of Immune Tolerance Induction (ITI) with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Compared to Conventional Recombinant Factor VIII (rFVIII)

Costs of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) - an Analysis of German Claims Data

The Immune Tolerance Induction Factor Utilizations and Costs for the Management of Male Hemophilia-a Patients Who Developed Inhibitors

Suppression of the Immune Response to Human FVIII with FVIII Transgene Modified Tolerogenic Dendritic Cells in Hemophilic Mice

Induction of Tolerance to FVIII in Hemophilic Mice by Delivery of Apoptotic Syngeneic Fibroblasts Expressing a FVIII Transgene.

Reduction of Anti-FVIII Inhibitor Titers in Hemophilic Mice Infused with Syngeneic Apoptotic Cells Expressing a Human FVIII Transgene.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only